Showing 441 - 460 results of 646 for search '"metabolic syndrome"', query time: 0.07s Refine Results
  1. 441
  2. 442

    Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand? by Ivana Mikolasevic, Tajana Pavic, Tajana Filipec Kanizaj, Darija Vranesic Bender, Viktor Domislovic, Zeljko Krznaric

    Published 2020-01-01
    “…The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it is evident that they share several common features. …”
    Get full text
    Article
  3. 443

    Probiotics, metabolism and the functional condition of cardio-vascular system by Ye. A. Kashukh, V. T. Ivashkin

    Published 2016-08-01
    “…Obtained data demonstrate that intake of certain probiotic strains may be applied as a successful treatment of atherosclerosis, systemic hypertension, metabolic syndrome and heart failure. Conclusion. Microbiome may be involved in development of cardio-vascular diseases and atherosclerosis due to metabolic symbiosis with the host. …”
    Get full text
    Article
  4. 444

    Role of PPARα and Its Agonist in Renal Diseases by Ching-Feng Cheng, Hsi-Hsien Chen, Heng Lin

    Published 2010-01-01
    “…In clinical application, PPAR-α activators, such as hypolipidemic drugs in fibric acid class, were proven to have therapeutic effects on metabolic syndrome and cardiovascular disease. This paper focuses on signaling pathways, ligand selectivity, and physio-pathological roles of PPARα in kidney diseases and the therapeutic utility of PPARα modulators in the treatment of diabetes and inflammation-induced nephropathy. …”
    Get full text
    Article
  5. 445

    Antiseizure medications and their differing effects on cardiovascular risk by Aleena Abbasi, Bassil Abbasi, Scott Mintzer, Carla LoPinto-Khoury

    Published 2025-03-01
    “…The overall atherosclerotic risk picture is more complex due to indirect effects such as neuroendocrine function and the metabolic syndrome. Large scale data shows an evolving understanding of cardiovascular risk. …”
    Get full text
    Article
  6. 446

    RETRACTED ARTICLE: Navigating the crossroads: cardiometabolic risks in cancer survivorship – a comprehensive review by Arif Albulushi, Aisha Al Balushi, Muhhamed Shahzad, Ismail Al Bulushi, Hatim Al Lawati

    Published 2024-08-01
    “…This manuscript synthesizes findings from various studies, highlighting the prevalence of traditional risk factors—hypertension, dyslipidemia, diabetes—as well as emergent concerns like obesity and metabolic syndrome among survivors. The impact of demographic variables, specific cancer types, and treatment modalities on cardiometabolic health is explored. …”
    Get full text
    Article
  7. 447
  8. 448

    Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs by Xing Wan, Jingyuan Ma, He Bai, Xuyang Hu, Yanna Ma, Mingjian Zhao, Jifeng Liu, Zhijun Duan

    Published 2025-01-01
    “…Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is closely associated with metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome. However, effective treatment strategies for NAFLD are still lacking. …”
    Get full text
    Article
  9. 449

    From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines by Chiara Sartori, Pietro Lazzeroni, Silvia Merli, Viviana Dora Patianna, Francesca Viaroli, Francesca Cirillo, Sergio Amarri, Maria Elisabeth Street

    Published 2016-01-01
    “…Adipokines play a significant role in the metabolic syndrome and in cardiovascular diseases, have implications in regulating insulin sensitivity and inflammation, and have significant effects on growth and reproductive function. …”
    Get full text
    Article
  10. 450

    Who will carry out the tests that would be necessary for proper safety evaluation of food emulsifiers? by Katalin F. Csáki, Éva Sebestyén

    Published 2019-06-01
    “…Moreover, it has recently been suggested that emulsifier consumption might contribute to the development of metabolic syndrome and can promote colitis-associated colorectal cancer also. …”
    Get full text
    Article
  11. 451

    Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity by Marwan El Ghoch, Paola Vittoria Bazzani, Simona Calugi, Riccardo Dalle Grave

    Published 2018-01-01
    “…Hence, the aim of this case report was to describe the clinical presentation and weight management of a 31-year-old male patient with spinal muscular atrophy type III, class I obesity, and metabolic syndrome treated for 1 year by means of a personalised multistep cognitive-behavioural treatment for obesity. …”
    Get full text
    Article
  12. 452

    On the development of diagnostic support algorithms based on CPET biosignals data via machine learning and wavelets by Rafael F. Pinheiro, Rui Fonseca-Pinto

    Published 2025-01-01
    “…This article introduces an algorithm that builds upon an earlier methodology to assess biosignals acquired through cardiopulmonary exercise testing (CPET) for identifying metabolic syndrome (MS), heart failure (HF), and healthy individuals (H). …”
    Get full text
    Article
  13. 453

    The role of immunity in insulin resistance in patients with polycystic ovary syndrome by Qixuan Zhang, Zhe Yang, Xiangyang Ou, Mengying Zhang, Xiangyu Qin, Gengxiang Wu

    Published 2025-01-01
    “…Polycystic ovary syndrome (PCOS) is a prevalent disorder of the endocrine system with significant clinical implications, often leading to health complications related to adipose tissue accumulation, including obesity, insulin resistance (IR), metabolic syndrome, and type 2 diabetes mellitus. While the precise pathogenesis of PCOS remains unclear, it is now recognized that genetic, endocrine, and metabolic dysregulations all contribute significantly to its onset. …”
    Get full text
    Article
  14. 454

    Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease by Longbiao Yao, Oana Herlea-Pana, Janet Heuser-Baker, Yitong Chen, Jana Barlic-Dicen

    Published 2014-01-01
    “…This low-grade chronic inflammation is thought to link obesity to insulin resistance and the associated comorbidities of metabolic syndrome such as dyslipidemia and hypertension, which increase risk of type 2 diabetes and cardiovascular disease. …”
    Get full text
    Article
  15. 455

    Peran Antioksidan pada Non Alcoholic Fatty Liver Disease (NAFLD) by Yusri Diane Jurnalis, Yorva Sayoeti, Elfitrimelly .

    Published 2014-01-01
    “…NAFLD related with obesity, type 2 diabetes mellitus and metabolic syndrome. Insulin resistance and oxidative stress have important role in molecular pathogenesis of NAFLD. …”
    Get full text
    Article
  16. 456

    The Importance of Magnesium in Clinical Healthcare by Gerry K. Schwalfenberg, Stephen J. Genuis

    Published 2017-01-01
    “…Level I evidence supports the use of magnesium in the prevention and treatment of many common health conditions including migraine headache, metabolic syndrome, diabetes, hyperlipidemia, asthma, premenstrual syndrome, preeclampsia, and various cardiac arrhythmias. …”
    Get full text
    Article
  17. 457

    The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus by Pegah Yousefzadeh, Xiangbing Wang

    Published 2013-01-01
    “…We conducted a search of PubMed and MEDLINE database, using the term DPP-4 inhibitor in combination with the following terms: metabolic syndrome, hypertension, dyslipidemia, insulin resistance, obesity, and CVD. …”
    Get full text
    Article
  18. 458

    Vascular Remodeling in Experimental Hypertension by Norma R. Risler, Montserrat C. Cruzado, Roberto M. Miatello

    Published 2005-01-01
    “…This review will provide an overview of the evidence, explaining some of the pathophysiologic mechanisms participating in the development of the vascular remodeling, in experimental models of hypertension, with special reference to the findings in spontaneously hypertensive rats as a model of essential hypertension, and in fructose-fed rats as a model of secondary hypertension, in the context of the metabolic syndrome. The understanding of the mechanisms producing the vascular alterations will allow the development of novel pharmacological tools for vascular protection in hypertensive disease.…”
    Get full text
    Article
  19. 459

    Association of Insomnia, Lipid Profile, and Lipid-Lowering Medications: A Narrative Review by Fang Jia, Shun-Yi Shi, Si-Fan Fei, Min Zhou, Jian-Jun Li

    Published 2025-01-01
    “…Interestingly, several previous studies have examined the potential relation of insomnia to metabolic syndrome and hyperlipidemia and found that insomnia was associated with elevated plasma cholesterol and triglyceride concentrations. …”
    Get full text
    Article
  20. 460

    The role of insulin signaling with FOXO and FOXK transcription factors by Masaji Sakaguchi

    Published 2024-10-01
    “…In both mice and humans, excessive dietary intake can lead to insulin resistance in various organs, ultimately displaying metabolic syndrome and type 2 diabetes. Insulin signals require thorough regulation to maintain metabolism across diverse environments. …”
    Get full text
    Article